Dig Your Heels In: A Working Woman’s Series with Jolene Delisle

A captivating story is often vital in building a successful business. Jolene Delisle, Founder and Head Creative at The Working Assembly, a branding and creative industry for clients at various life stages, recognized the need for brands to refine, synthesize, and market themselves throughout their life cycles using storytelling. Delisle sits down with host Gabrielle Bejarano to remark on her journey as a woman founder in the branding industry.

“Advertising was really the place where storytellers go,” remarked Delisle, noting that her time in advertising helped push her to find her LLC and start consulting one-on-one with other female founders.

During the “silicon-alley” movement in NYC, which saw the rise of many start-ups, “There were a lot of female founders coming out who didn’t necessarily have that support or that infrastructure of a branding agency, they couldn’t really fully support that financially. And so, I was able to kind of consult with some of those founders and work with them directly and I realized it was so positive, such a positive experience,” said Delisle.

While pregnant with her daughter, Delisle made The Working Assembly a full-time gig.

Delisle wanted to make sure her company could reach and support the smaller start-ups and clients, “We’re able to really support our clients in a way that feels agile, it feels, you know, not rigid, we’re really augmenting to them and their process and their team. But we’re also able to supply a lot of diversity of thought.”

The Working Assembly brought a new outlook to the industry, “So I thought: How cool would it be if we had a branding agency that could, you know, at least help with the initial launch and campaign aspects?…” remarked Delisle.

With the most recent data from Zippia showing nearly 64% of men are Creative Directors while only 35% are women, Delisle noted that her workers do interact with her a bit differently than her male counterpart, but, “It’s just something that we, as a society, are starting to really kind of reconcile and understand now…”

Follow us on social media for the latest updates in B2B!

Image

Latest

Evolving Biomarkers: Charting the Future of Precision Medicine
April 19, 2025

In a rapidly shifting landscape of personalized medicine, biomarkers have become central to shaping the way drug development and clinical trials unfold. From predicting therapeutic response to identifying optimal patient populations, the complexity and scope of biomarker use has increased alongside technological advances. A key success story like the BCR-ABL biomarker in chronic myeloid leukemia…

Read More
Drug Discovery
Exploring Artificial Intelligence in Drug Discovery
April 19, 2025

Artificial intelligence is rapidly reshaping the drug discovery process, moving from augmenting research to actively driving innovation. As biotech companies face soaring R&D costs and long development cycles, AI promises a breakthrough: slashing drug development time by nearly half while improving accuracy in identifying promising compounds. With global pharmaceutical R&D spending projected to exceed $230…

Read More
KRAS
Pioneering Strategies to Unlocking the Potential of KRAS
April 18, 2025

Once labeled “undruggable,” KRAS has emerged as one of oncology’s most promising—yet complex—targets. With nearly 90% of pancreatic cancers and 30-40% of lung and colorectal cancers harboring KRAS mutations, the need for effective therapies is urgent. Recent FDA approvals of KRAS G12C inhibitors have signaled a new era, but the rise of resistance and diverse…

Read More
Polygon: Transforming Project Visions into Success Stories
April 18, 2025

Every successful project begins with a vision. The journey from ideation to fruition might seem daunting, but with the right toolkit and a trusted partner, your goals are within reach. This is where Polygon steps in. Tailoring solutions to match your unique needs, we ensure your projects kick start on a robust footing and…

Read More